Company page

Liquidia Corporation

Liquidia Corporation, trading under the ticker LQDA, is a public company based in the United States with a market capitalization of approximately $5.5 billion. The company focuses on developing and commercializing innovative therapies for patients with serious diseases. Liquidia is committed to advancing its proprietary technologies to improve treatment options in the healthcare sector.